Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-26 @ 2:57 AM
Study NCT ID:
NCT01270802
Status:
COMPLETED
Last Update Posted:
2013-12-18
First Post:
2011-01-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
Sponsor:
Indiana University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-04
First Submit QC Date:
None
Study First Post Date:
2011-01-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-14
Results First Submit QC Date:
None
Results First Post Date:
2013-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-24
Last Update Post Date:
2013-12-18
Last Update Post Date Type:
ESTIMATED